Fabio Giannessi

530 total citations
24 papers, 416 citations indexed

About

Fabio Giannessi is a scholar working on Molecular Biology, Clinical Biochemistry and Organic Chemistry. According to data from OpenAlex, Fabio Giannessi has authored 24 papers receiving a total of 416 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Clinical Biochemistry and 6 papers in Organic Chemistry. Recurrent topics in Fabio Giannessi's work include Metabolism and Genetic Disorders (8 papers), Analytical Chemistry and Chromatography (4 papers) and Asymmetric Synthesis and Catalysis (4 papers). Fabio Giannessi is often cited by papers focused on Metabolism and Genetic Disorders (8 papers), Analytical Chemistry and Chromatography (4 papers) and Asymmetric Synthesis and Catalysis (4 papers). Fabio Giannessi collaborates with scholars based in Italy, Switzerland and Egypt. Fabio Giannessi's co-authors include Paolo Carminati, Roberto Conti, Arduino Arduini, Maria Ornella Tinti, Francesco De Angelis, Edoardo Mannucci, Ferdinando Maria Milazzo, Daniela Barlocco, Luciano Antolini and Laura Raimondi and has published in prestigious journals such as Diabetes, Chemical Communications and Journal of Medicinal Chemistry.

In The Last Decade

Fabio Giannessi

24 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fabio Giannessi Italy 12 234 99 85 59 50 24 416
Kyriaki Pegklidou Greece 8 172 0.7× 124 1.3× 119 1.4× 75 1.3× 63 1.3× 9 499
Carmen Cascales Spain 11 219 0.9× 60 0.6× 32 0.4× 41 0.7× 36 0.7× 20 479
Koichi Itakura Japan 12 285 1.2× 121 1.2× 90 1.1× 125 2.1× 17 0.3× 23 625
Zaid Jayyosi United States 13 149 0.6× 149 1.5× 23 0.3× 29 0.5× 52 1.0× 21 593
Akihiro Sekiguchi Japan 10 225 1.0× 173 1.7× 16 0.2× 39 0.7× 49 1.0× 15 528
Hongchan An South Korea 14 228 1.0× 180 1.8× 33 0.4× 34 0.6× 18 0.4× 35 482
Laurie L. McLeod United States 8 240 1.0× 60 0.6× 17 0.2× 71 1.2× 55 1.1× 8 511
Chaitanya A. Kulkarni United States 10 204 0.9× 56 0.6× 25 0.3× 63 1.1× 21 0.4× 17 367
Hans-Jörg Burger Germany 10 218 0.9× 47 0.5× 46 0.5× 21 0.4× 68 1.4× 14 622
Christian J. Mularski United States 6 184 0.8× 101 1.0× 22 0.3× 56 0.9× 23 0.5× 8 337

Countries citing papers authored by Fabio Giannessi

Since Specialization
Citations

This map shows the geographic impact of Fabio Giannessi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabio Giannessi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabio Giannessi more than expected).

Fields of papers citing papers by Fabio Giannessi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabio Giannessi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabio Giannessi. The network helps show where Fabio Giannessi may publish in the future.

Co-authorship network of co-authors of Fabio Giannessi

This figure shows the co-authorship network connecting the top 25 collaborators of Fabio Giannessi. A scholar is included among the top collaborators of Fabio Giannessi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabio Giannessi. Fabio Giannessi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Conti, Roberto, et al.. (2011). Derivatives of R‐Aminocarnitine without Ammonium Moiety as Liver Carnitine Palmitoyltransferase I (L‐CPT I) Inhibitors. ChemMedChem. 6(11). 1977–1980. 2 indexed citations
3.
Coccurello, Roberto, Antonio Caprioli, Francesca R. D’Amato, et al.. (2010). Effects of the increase in neuronal fatty acids availability on food intake and satiety in mice. Psychopharmacology. 210(1). 85–95. 15 indexed citations
4.
Conti, Roberto, Grazia Gallo, Silvia Vincenti, et al.. (2010). Aminocarnitine Ureidic Derivatives as Inhibitors of Carnitine Palmitoyltransferase I. ChemMedChem. 5(5). 666–669. 6 indexed citations
6.
Peschechera, Alessandro, et al.. (2005). Carnitine depletion in rat pups from mothers given mildronate: A model of carnitine deficiency in late fetal and neonatal life. Life Sciences. 77(24). 3078–3091. 16 indexed citations
7.
Milazzo, Ferdinando Maria, Francesco De Angelis, Alessandro Peschechera, et al.. (2005). 2‐{3‐[2‐(4‐Chlorophenyl)ethoxy]phenylthio}‐2‐methylpropanoic Acid: a Fibrate‐Like Compound with Hypolipidemic and Antidiabetic Activity. ChemMedChem. 1(1). 49–53. 3 indexed citations
8.
Raimondi, Laura, et al.. (2004). Isolation and Pharmacological Activities of the Tecoma Stans Alkaloids.. ChemInform. 35(4). 2 indexed citations
9.
Perrone, Maria Grazia, et al.. (2004). Synthesis and biological evaluation of new clofibrate analogues as potential PPARα agonists. European Journal of Medicinal Chemistry. 40(2). 143–154. 19 indexed citations
10.
Costantino, Luca, Laura Raimondi, R. Pirisino, et al.. (2003). Isolation and pharmacological activities of the Tecoma stans alkaloids. Il Farmaco. 58(9). 781–785. 62 indexed citations
12.
Gasparrini, Francesco, et al.. (2002). The first gas chromatographic resolution of carnitine enantiomers. Chemical Communications. 474–475. 2 indexed citations
13.
Giannessi, Fabio, Roberto Conti, Francesco De Angelis, et al.. (2002). Discovery of a Long-Chain Carbamoyl Aminocarnitine Derivative, a Reversible Carnitine Palmitoyltransferase Inhibitor with Antiketotic and Antidiabetic Activity. Journal of Medicinal Chemistry. 46(2). 303–309. 60 indexed citations
14.
Angelis, Francesco De, et al.. (1999). Inversion of Configuration of (S)-β-Hydroxy-γ-butyrolactone with Total Retention of the Enantiomeric Purity. European Journal of Organic Chemistry. 1999(11). 2705–2707. 2 indexed citations
15.
Angelis, Francesco De, et al.. (1996). The β‐Lactone Route to a Totally Stereoselective Synthesis of Carnitine Derivatives. Chemistry - A European Journal. 2(7). 826–831. 16 indexed citations
16.
Angelis, Francesco De, et al.. (1994). Vollständig enantioselektive Inversion der Konfiguration von (S)‐( + )‐Carnitinen. Angewandte Chemie. 106(20). 2202–2203. 2 indexed citations
17.
Angelis, Francesco De, et al.. (1994). Totally Enantioselective Inversion of Configuration of (S)‐(+)‐Carnitine Derivatives. Angewandte Chemie International Edition in English. 33(20). 2076–2078. 8 indexed citations
18.
Angelucci, Luciano, Ugo Cosentino, Roberto Cozzolino, et al.. (1993). Synthesis and amnesia-reversal activity of a series of 7- and 5-membered 3-acylamino lactams. Journal of Medicinal Chemistry. 36(11). 1511–1519. 10 indexed citations
19.
Cosentino, Ugo, Giorgio Moro, Demetrio Pitea, et al.. (1990). Pharmacophore Identification in Amnesia‐Reversal Compounds Using Conformational Analysis and Chemometric Methods. Quantitative Structure-Activity Relationships. 9(3). 195–201. 9 indexed citations
20.
Conte, G. & Fabio Giannessi. (1987). A case of the transposition of the great arteries in a rabbit embryo.. PubMed. 63(4). 323–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026